Bär & Karrer advised Tecan on the issuance of CHF 150 Million bonds
On 14 August 2025 Tecan Group Ltd. (SIX Swiss Exchange: TECN) successfully issued CHF 150 million 0.85% fixed rate domestic straight bonds due 2030. The bonds are listed and traded on the SIX Swiss Exchange. UBS Investment Bank and Zürcher Kantonalbank acted as joint lead managers, with Bank J. Safra Sarasin serving as co-lead manager.
Hogan Lovells berät PATRIZIA beim Erwerb einer Seniorenresidenz von Cureus
11. Dezember 2025 – Unter der Leitung der Hamburger Counsel Claudia Wolf hat die globale Wirtschaftskanzlei Hogan Lovells den internationalen Investmentmanager für Immobilien und Infrastruktur PATRIZIA beim Erwerb einer Seniorenresidenz im Rahmen eines Asset Deals von Cureus, einem auf stationäre Pflegeimmobilien spezialisierten Entwickler und Bestandshalter, beraten.
Gernandt & Danielsson advises ADDvise in connection with a public offer from Amplex
On 10 December 2025, Amplex AB announced a public cash offer to the shareholders of ADDvise Group AB (publ). The offer values all shares and warrants in ADDvise at SEK 1.05 billion. The board of directors of ADDvise will evaluate the offer and announce a statement with its opinion regarding the offer and a fairness …
Bär & Karrer Advises L’Oréal on the increase of its stake in Galderma from 10% to 20%
L’Oréal, the world leader in beauty, acquires an additional 10% stake in Galderma Group AG (Galderma), the pure-play dermatology category leader and one of the world’s largest players in injectable aesthetics, from Sunshine SwissCo AG, Abu Dhabi Investment Authority, and Auba Investment Pte. Ltd. (a consortium led by EQT).
Chambers & Partners recognises Arbor Law for its distinctive “Big Law without the baggage” model.
Arbor Law has been recognised in the Chambers UK 2025 Guide for its outstanding work supporting small and medium-sized enterprises (SMEs) across the UK – a testament to the firm’s innovative, senior-only model that combines City-firm expertise with in-house commercial insight, designed to eliminate inefficiency and make excellence more accessible to small and mid-sized businesses seeking legal support.
Regulation of Clinical Trials in the Republic of Kazakhstan
What is a clinical trial? A clinical trial (“CT”) is a study involving human subjects, conducted to identify or confirm the safety and effectiveness of means, methods, and technologies for the prevention, diagnosis, and treatment of diseases. What types of CTs are there? A non-interventional CT is a study which is conducted after the state …
Continue reading “Regulation of Clinical Trials in the Republic of Kazakhstan”
Commerce Legislation News Uzbekistan – November 2025 The regulatory framework governing trade activities in the Republic of Uzbekistan (hereinafter referred to as “Uzbekistan”) has undergone significant amendments designed to strengthen consumer protection mechanisms. Below is an overview of the key developments. The Government has approved new regulations governing promotional campaigns and discounts in retail trade. …
Gernandt & Danielsson advises Worldline in connection with the contemplated divestment of its payment orchestration platform PaymentIQ
Gernandt & Danielsson advises Worldline, a European leader in payment services, in connection with the divestment of PaymentIQ, a payment orchestration platform, to Incore Invest for an estimated cash proceeds at closing of c. EUR 160 million, after excess cash distribution.
Argus Partners Advises Ripplr on its USD 45 million Series C fundraise
Argus Partners is pleased to announce that it has advised Intelligent Retail Private Limited (“Ripplr”), a technology driven distribution and supply chain platform, in connection with its Series C fundraise. The funding round, comprising a mix of primary and secondary transactions, along with debt, witnessed participation from new investor State Bank of India, as well …
Continue reading “Argus Partners Advises Ripplr on its USD 45 million Series C fundraise”
Homburger advises EQT on the sale of an additional 10% in Galderma to L’Oréal, reinforcing L’Oréal’s strategic investment in Galderma
On December 8, 2025, EQT announced the sale of an additional 10% stake in Galderma Group AG (SIX: GALD) by a consortium led by EQT, which includes Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as sellers) to L’Oréal S.A. for an undisclosed amount. Following the transaction, …